These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8118874)
1. Monoclonal antibody, LR-2, recognizes an immunoglobulin-linked signaling molecule on murine B cells. Marshall-Clarke S; Greenwood M Cell Immunol; 1994 Feb; 153(2):428-42. PubMed ID: 8118874 [TBL] [Abstract][Full Text] [Related]
2. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
3. Signaling properties of anti-immunoglobulin--resistant variants of WEHI-231 B lymphoma cells. Benhamou LE; Watanabe T; Kitamura D; Cazenave PA; Sarthou P Eur J Immunol; 1994 Sep; 24(9):1993-9. PubMed ID: 8088319 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Santos-Argumedo L; Gordon J; Heath AW; Howard M Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793 [TBL] [Abstract][Full Text] [Related]
5. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations. Mongini PK; Blessinger C; Posnett DN; Rudich SM J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188 [TBL] [Abstract][Full Text] [Related]
6. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. Lederman S; Yellin MJ; Cleary AM; Pernis A; Inghirami G; Cohn LE; Covey LR; Lee JJ; Rothman P; Chess L J Immunol; 1994 Mar; 152(5):2163-71. PubMed ID: 7907632 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation. Monroe JG J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226 [TBL] [Abstract][Full Text] [Related]
8. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells. Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637 [TBL] [Abstract][Full Text] [Related]
9. Role of mu heavy chain in B cell development. I. Blocked B cell maturation but complete allelic exclusion in the absence of Ig alpha/beta. Cronin FE; Jiang M; Abbas AK; Grupp SA J Immunol; 1998 Jul; 161(1):252-9. PubMed ID: 9647231 [TBL] [Abstract][Full Text] [Related]
10. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion. Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. Tutt AL; French RR; Illidge TM; Honeychurch J; McBride HM; Penfold CA; Fearon DT; Parkhouse RM; Klaus GG; Glennie MJ J Immunol; 1998 Sep; 161(6):3176-85. PubMed ID: 9743386 [TBL] [Abstract][Full Text] [Related]
12. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. Pezzutto A; Dörken B; Moldenhauer G; Clark EA J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151 [TBL] [Abstract][Full Text] [Related]
13. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines. Scott DW; O'Garra A; Warren D; Klaus GG J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold. Veri MC; Burke S; Huang L; Li H; Gorlatov S; Tuaillon N; Rainey GJ; Ciccarone V; Zhang T; Shah K; Jin L; Ning L; Minor T; Moore PA; Koenig S; Johnson S; Bonvini E Arthritis Rheum; 2010 Jul; 62(7):1933-43. PubMed ID: 20506263 [TBL] [Abstract][Full Text] [Related]
15. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells. Sarthou P; Henry-Toulmé N; Cazenave PA Eur J Immunol; 1989 Jul; 19(7):1247-52. PubMed ID: 2668012 [TBL] [Abstract][Full Text] [Related]
16. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells. Boyd AW; Pike BL Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696 [TBL] [Abstract][Full Text] [Related]
17. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules. Bartnes K; Hannestad K Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601 [TBL] [Abstract][Full Text] [Related]
18. Early B cell development requires mu signaling. Iglesias A; Nichogiannopoulou A; Williams GS; Flaswinkel H; Köhler G Eur J Immunol; 1993 Oct; 23(10):2622-30. PubMed ID: 8405063 [TBL] [Abstract][Full Text] [Related]
19. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1. Tamura GS; McGrath MS; Weissman IL J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925 [TBL] [Abstract][Full Text] [Related]
20. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice. de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]